TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biotechst Lund AB
Closing information (x1000 NOK)
| Closing information | 2022/08 | 2021/08 | 2020/08 |
| Turnover |
740
|
703
|
719 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
67
|
11
|
3 |
| EBITDA |
67
|
11
|
3 |
| Total assets |
464
|
443
|
430 |
| Current assets |
464
|
443
|
430 |
| Current liabilities |
155
|
170
|
165 |
| Equity capital |
308
|
273
|
265 |
| - share capital |
92
|
101
|
102 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/08 | 2021/08 | 2020/08 |
| Solvency |
66.4%
|
61.6%
|
61.6% |
| Turnover per employee |
740
|
703
|
719 |
| Profit as a percentage of turnover |
9.1%
|
1.6%
|
0.4% |
| Return on assets (ROA) |
14.4%
|
2.5%
|
0.7% |
| Current ratio |
299.4%
|
260.6%
|
260.6% |
| Return on equity (ROE) |
21.8%
|
4.0%
|
1.1% |
| Change turnover |
97
|
-7
|
-60 |
| Change turnover % |
15%
|
-1%
|
-8% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/08 | 2021/08 | 2020/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.